Alpha 2.0
Login Register
» Articles » PMID: 6101481

Captoril-associated Agranulocytosis

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1980 Jan 19
PMID 6101481
Citations 10
Authors
F W Amann
F R Buhler
D Conen
F Brunner
R Ritz
B Speck
Affiliations
Soon will be listed here.
Citing Articles

Selecting appropriate antihypertensive drug dosages.

Johnston G Drugs. 1994; 47(4):567-75.

PMID: 7516856 DOI: 10.2165/00003495-199447040-00001.

Control of essential hypertension with captopril, an angiotensin converting enzyme inhibitor.

el-MEHAIRY M, Shaker A, Ramadan M, Hamza S, Tadros S Br J Clin Pharmacol. 1981; 11(5):469-75.

PMID: 7023522 PMC: 1401594. DOI: 10.1111/j.1365-2125.1981.tb01152.x.

Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.

Heel R, Brogden R, Speight T, Avery G Drugs. 1980; 20(6):409-52.

PMID: 7009133 DOI: 10.2165/00003495-198020060-00001.

Fatal bone-marrow suppression associated with captopril.

Larabi M, Kechrid C, Belkahia C, Ben Ayed H Br Med J (Clin Res Ed). 1981; 283(6286):277-8.

PMID: 6788292 PMC: 1506343. DOI: 10.1136/bmj.283.6286.277-a.

Long-term efficacy of angiotensin-converting-enzyme inhibition with captopril in mild-to-moderate essential hypertension.

Stumpe K, Overlack A, Kolloch R, Schreyer S Br J Clin Pharmacol. 1982; 14 Suppl 2:121S-126S.

PMID: 6291563 PMC: 1427503. DOI: 10.1111/j.1365-2125.1982.tb02068.x.